GLP-1 Copycats Are Out—Now What?

If you’ve been getting those off-brand GLP-1 shots (like semaglutide or tirzepatide), heads up: the FDA just banned compounded versions due to safety risks. That means no more copycat meds, and supplies are about to vanish. Compounded versions could have sketchy ingredients or wrong doses—yikes. If you’re affected, talk to your doc ASAP about switching to the real deal or exploring other safe, FDA-approved options. Don’t risk it with mystery meds! #GLP1 #FDAUpdate #HealthNews #Health